$1.04 Billion is the total value of Alphabet Inc.'s 17 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JD | JD com Incspon adr cl a | $353,610,000 | -33.0% | 13,553,474 | 0.0% | 33.87% | -23.6% | |
| ARRS | Arris Intl Inc | $252,194,000 | +6.3% | 9,703,500 | 0.0% | 24.16% | +21.2% | |
| DOCU | DocuSign Inc | $76,810,000 | -0.7% | 1,461,106 | 0.0% | 7.36% | +13.2% | |
| SVMK | New | SVMK Inc | $73,878,000 | – | 4,608,705 | +100.0% | 7.08% | – |
| RCUS | Arcus Biosciences Inc | $70,394,000 | +13.9% | 5,049,786 | 0.0% | 6.74% | +29.9% | |
| ZS | Sell | Zscaler Inc | $59,058,000 | -40.8% | 1,448,219 | -48.1% | 5.66% | -32.4% |
| MGTA | Magenta Therapeutics Inc | $40,103,000 | -11.0% | 3,339,138 | 0.0% | 3.84% | +1.4% | |
| FTSV | Forty Seven Inc | $23,066,000 | -6.7% | 1,545,966 | 0.0% | 2.21% | +6.4% | |
| SNAP | Snap Inccl a | $22,205,000 | -35.2% | 2,618,548 | 0.0% | 2.13% | -26.1% | |
| AUTL | Autolus Therapeutics PLCspon ads | $21,901,000 | +14.5% | 714,072 | 0.0% | 2.10% | +30.6% | |
| GRTS | New | Gritstone Oncology Inc | $13,229,000 | – | 929,022 | +100.0% | 1.27% | – |
| EVLO | Evelo Biosciences Inc | $12,917,000 | +3.2% | 1,060,495 | 0.0% | 1.24% | +17.7% | |
| SPRO | Spero Therapeutics Inc | $11,692,000 | -28.4% | 1,112,473 | 0.0% | 1.12% | -18.3% | |
| CLDR | Sell | Cloudera Inc | $7,549,000 | -35.3% | 427,710 | -50.0% | 0.72% | -26.2% |
| PS | Pluralsight Inccl a | $3,246,000 | +30.9% | 101,442 | 0.0% | 0.31% | +49.5% | |
| SPOT | New | Spotify Technology S A | $1,744,000 | – | 9,646 | +100.0% | 0.17% | – |
| DBX | Dropbox Inccl a | $350,000 | -17.3% | 13,033 | 0.0% | 0.03% | -5.6% | |
| SQ | Exit | Square Inccl a | $0 | – | -29,400 | -100.0% | -0.15% | – |
| DNLI | Exit | Denali Therapeutics Inc | $0 | – | -536,411 | -100.0% | -0.69% | – |
| ASNS | Exit | Arsanis Inc | $0 | – | -451,362 | -100.0% | -0.83% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-04-30 |
| 4 | 2024-04-30 |
| 10-Q | 2024-04-26 |
| 144 | 2024-04-26 |
| 4 | 2024-04-26 |
| 4 | 2024-04-26 |
| ARS | 2024-04-26 |
| DEF 14A | 2024-04-26 |
| DEFA14A | 2024-04-26 |
| 8-K | 2024-04-25 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.